Sale!

Targeted Mutation Analysis More Than 2 Mutations Test

Original price was: 5,200 د.إ.Current price is: 3,900 د.إ.

-25%

The “Targeted Mutation Analysis More Than 2 Mutations Test” offered by DNA Labs UAE is a specialized genetic test designed to identify the presence of specific mutations across various genes. This test is particularly useful for individuals with a family history of genetic disorders, or for those who are at risk of hereditary diseases. By analyzing more than two genetic mutations, the test provides a comprehensive overview of the individual’s genetic predisposition to certain conditions, enabling precise and personalized medical interventions.

The process involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing technologies. This allows for the accurate detection of specific mutations that could be linked to a wide range of genetic disorders.

Priced at 3900 AED, the test is a valuable tool for early detection and preventive healthcare planning. It offers insights that can guide healthcare providers in developing targeted treatment plans, lifestyle adjustments, or preventive measures to mitigate the risk of developing genetic conditions. Conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic testing, patients can expect reliable and comprehensive results that can significantly impact their health management strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Targeted Mutation Analysis more than 2 Mutations Test

Test Cost: AED 3900.0

Symptoms and Diagnosis

If you suspect the presence of multiple mutations in a specific gene or genomic region, the targeted mutation analysis can help in identifying and analyzing these mutations. This test is commonly used in genetics and can provide valuable insights into the genetic variations present.

Test Components

  • EDTA Vacutainer (2ml)/ Sterile Container

Sample Condition

The test can be performed on the following sample types:

  • Peripheral blood
  • Plasma
  • Serum
  • Amniotic fluid
  • Cord Blood
  • Chorionic villi

Report Delivery

The test results will be delivered within 10-15 days after sample submission.

Method

The targeted mutation analysis is performed using the Sanger sequencing method, which is a widely used technique in genetics.

Test Type

This test falls under the category of genetics.

Doctor

A gynecologist can prescribe this test.

Test Department

This test is conducted in the genetics department of the DNA Labs UAE.

Pre Test Information

Targeted mutation analysis (more than 2 mutations) can be done with a doctor’s prescription. However, please note that the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Test Details

Targeted mutation analysis refers to the process of specifically identifying and analyzing mutations in a targeted region of the genome. This can involve the identification of single mutations or multiple mutations in a specific gene or genomic region.

When it comes to analyzing more than two mutations, the process becomes more complex. Here are the key steps involved:

  1. Target selection: Identify the specific gene or genomic region of interest where the mutations are suspected to be present. This can be based on previous knowledge or specific research questions.
  2. Sample collection: Obtain samples containing the DNA of interest, such as blood, tissue, or cells. These samples can be from individuals or experimental models.
  3. DNA extraction: Isolate the DNA from the collected samples using standard techniques. This ensures that the DNA is pure and suitable for subsequent analysis.
  4. Mutation detection: Use appropriate molecular techniques to detect and identify mutations in the targeted region. This can include PCR (polymerase chain reaction), DNA sequencing, or other methods such as Sanger sequencing or next-generation sequencing (NGS).
  5. Data analysis: Analyze the obtained sequencing data to identify and characterize the mutations present in the targeted region. This can involve comparing the obtained sequences with a reference sequence or using bioinformatics tools to identify specific mutations.
  6. Validation: Validate the identified mutations using additional techniques, such as allele-specific PCR or functional assays, to confirm their presence and functional impact.
  7. Interpretation: Analyze and interpret the results to understand the potential implications of the identified mutations. This can involve considering the known function of the gene or genomic region, previous research findings, and clinical relevance.

It is important to note that targeted mutation analysis for multiple mutations can be time-consuming and technically challenging. It requires expertise in molecular biology techniques, bioinformatics, and genetic analysis. Additionally, the interpretation of the results may require collaboration with experts in the field, such as geneticists or clinicians, to understand the clinical significance of the identified mutations.

Test Name Targeted mutation Analysis more than 2 mutations Test
Components EDTA Vacutainer (2ml)/ Sterile Container
Price 3900.0 AED
Sample Condition Peripheral blood\/ Plasma\/ Serum\/ Amniotic fluid \/ Cord Blood\/Chorionic villi
Report Delivery 10-15 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information Targeted mutation Analysis (more than 2 mutations) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Targeted mutation analysis refers to the process of specifically identifying and analyzing mutations in a targeted region of the genome. This can involve the identification of single mutations or multiple mutations in a specific gene or genomic region.

When it comes to analyzing more than two mutations, the process becomes more complex. Here are some key steps involved in targeted mutation analysis for multiple mutations:

1. Target selection: Identify the specific gene or genomic region of interest where the mutations are suspected to be present. This can be based on previous knowledge or specific research questions.

2. Sample collection: Obtain samples containing the DNA of interest, such as blood, tissue, or cells. These samples can be from individuals or experimental models.

3. DNA extraction: Isolate the DNA from the collected samples using standard techniques. This ensures that the DNA is pure and suitable for subsequent analysis.

4. Mutation detection: Use appropriate molecular techniques to detect and identify mutations in the targeted region. This can include PCR (polymerase chain reaction), DNA sequencing, or other methods such as Sanger sequencing or next-generation sequencing (NGS).

5. Data analysis: Analyze the obtained sequencing data to identify and characterize the mutations present in the targeted region. This can involve comparing the obtained sequences with a reference sequence or using bioinformatics tools to identify specific mutations.

6. Validation: Validate the identified mutations using additional techniques, such as allele-specific PCR or functional assays, to confirm their presence and functional impact.

7. Interpretation: Analyze and interpret the results to understand the potential implications of the identified mutations. This can involve considering the known function of the gene or genomic region, previous research findings, and clinical relevance.

It is important to note that targeted mutation analysis for multiple mutations can be time-consuming and technically challenging. It requires expertise in molecular biology techniques, bioinformatics, and genetic analysis. Additionally, the interpretation of the results may require collaboration with experts in the field, such as geneticists or clinicians, to understand the clinical significance of the identified mutations.